Trial
NCT02780830
AZD2014 Plus Novel Anti-Cancer Agents in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
AstraZeneca
Collaborators
—
Condition
Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Intervention
AZD2014
Why stopped
Study D2276C00001 was not started. No patients were enrolled. The sponsor decided to pursue an alternate design.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-09-15